Sociodemographic and Clinical Factors Associated with COVID-19 Mortality in India: a Retrospective Study
- PMID: 40223849
- PMCID: PMC11986342
- DOI: 10.5455/aim.2024.33.23-29
Sociodemographic and Clinical Factors Associated with COVID-19 Mortality in India: a Retrospective Study
Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic significantly impacted global health, with India experiencing one of the highest case and death tolls. However, data specific to India's sociodemographic and clinical factors influencing COVID-19 mortality remains limited.
Objective: This study aimed to identify sociodemographic and clinical factors associated with COVID-19 mortality in India.
Methods: This retrospective, cross-sectional study analyzed medical records of 4961 adult COVID-19 patients admitted to a tertiary care center in North India, from April 2020 to December 2021. Sociodemographic and clinical data were captured using a structured proforma. Univariate analysis (chi-square test) and Kaplan-Meier survival analysis were performed to identify factors associated with mortality.
Results: Of the 4961 patients, 557 (11.2%) died, and 4404 (88.8%) survived. Increased age, rural residency, professional occupation, and comorbidities (diabetes and hypertension), multimorbidity, increased disease severity, cold and flu symptoms, breathlessness, and the need for intensive care unit (ICU) admission and ventilator support were significantly (P <0.05) associated with higher COVID-19 mortality. While some associations were observed with sociodemographic factors like religion, education level, and monthly family income in univariate analysis, these were not significant in survival analysis.
Conclusion: In this cohort of COVID-19 patients in India, advanced age, rural residency, professional occupation, comorbidities, multimorbidity, severe symptoms, and the need for ICU admission and ventilator support were identified as significant risk factors for mortality. Early identification and intervention for these high-risk groups may improve survival rates.
Keywords: COVID-19; India; comorbidity; mortality; risk factors.
© 2025 Lokesh Parashar, Himanshu Shekhar, Hina Arya, Shankar Lal Vig, Jagdish Prasad, Girish Gulab Meshram.
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose.
Figures


Similar articles
-
Evolution of COVID-19 mortality risk: A retrospective study of three epidemic waves in Faridabad, India.Semergen. 2025 May 8;51(6):102494. doi: 10.1016/j.semerg.2025.102494. Online ahead of print. Semergen. 2025. PMID: 40345023
-
Risk Factors associated with COVID-19 Patients in India: A Single Center Retrospective Cohort Study.J Assoc Physicians India. 2023 Jun;71(6):11-12. doi: 10.5005/japi-11001-0263. J Assoc Physicians India. 2023. PMID: 37355843
-
Association between body-mass index, patient characteristics, and obesity-related comorbidities among COVID-19 patients: A prospective cohort study.Obes Res Clin Pract. 2023 Jan-Feb;17(1):47-57. doi: 10.1016/j.orcp.2022.12.003. Epub 2022 Dec 20. Obes Res Clin Pract. 2023. PMID: 36577559 Free PMC article.
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. PMID: 32406927 Free PMC article. Updated.
-
Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1017-1025. doi: 10.1016/j.dsx.2020.06.064. Epub 2020 Jul 2. Diabetes Metab Syndr. 2020. PMID: 32634716 Free PMC article.
References
-
- World Health Organization: COVID-19 Epidemiological update - 6 November 2024. Available at URL: https://www.who.int/publications/m/item/covid-19-epidemiological-update-... (Accessed: 15.3.2025).
LinkOut - more resources
Full Text Sources
Miscellaneous